Olympus Partners has acquired PAI Pharma Read More
In response to FDA ban of Red No.3, PAI Pharma shares more than 60 products in the portfolio are dye-free. Read More
PAI Pharma is pleased to announce the acquisition of VistaPharm—a privately held, healthcare company that offers generic pharmaceuticals and over the counter products for hospitals, retail pharmacies, and the specialized clinical setting. Read More